Indeed, T lymphocytes were shown to promote BM in estrogen-negative breast cancer through the upregulation of guanylate-binding protein 1 (GBP1), which enhances the ability of breast cancer cells to cross the BBB [59]. Here, GBP1 is linked to breast carcinoma.